{"pmid": "11807794", "sentences": {"sent_1": {"Section": "", "text": "We utilized peripheral blood mononuclear cells ( PBMC ) obtained at leukapheresis from 6 breast cancer patients vaccinated 4 times each with a 106 - amino acid - long MUC1 peptide conjugated with KLH plus immune adjuvant QS - 21 .", "entities": {"entity_1": {"text": "peripheral blood mononuclear cells ( PBMC )", "class": "Intervention", "negation": 0, "UMLS": "C2243049:peripheral blood mononuclear cells,", "index": 1, "start": 2}, "entity_2": {"text": "cancer", "class": "Participant", "negation": 0, "UMLS": "C0006826:cancer,", "index": 2, "start": 15}, "entity_3": {"text": "KLH", "class": "Intervention", "negation": 0, "UMLS": "", "index": 3, "start": 33}}, "relations": {}}, "sent_2": {"Section": "", "text": "Proliferation after 6 days of in vitro culture and an interferon gamma ELISPOT assay with and without 6 days of in vitro sensitization with the immunizing antigen were used .", "entities": {"entity_4": {"text": "Proliferation", "class": "Outcome", "negation": 0, "UMLS": "C0334094:Proliferation,", "index": 1, "start": 0}, "entity_5": {"text": "vitro culture", "class": "Intervention", "negation": 0, "UMLS": "C0430400:culture,", "index": 2, "start": 6}, "entity_6": {"text": "interferon gamma ELISPOT", "class": "Intervention", "negation": 0, "UMLS": "C0021745:interferon gamma,C0920508:elispot,", "index": 3, "start": 10}, "entity_7": {"text": "vitro sensitization", "class": "Participant", "negation": 0, "UMLS": "C1325847:sensitization,", "index": 4, "start": 21}}, "relations": {}}, "sent_3": {"Section": "", "text": "Parallel experiments employed the use of the cytokine IL2 .", "entities": {"entity_8": {"text": "cytokine IL2", "class": "Outcome", "negation": 0, "UMLS": "", "index": 1, "start": 7}}, "relations": {}}}}